UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000010369
Receipt number R000012134
Scientific Title Phase I/II study on completion rate of concurrent chemoradiotherapy which regimen is assumed by only CDDP for head and neck squamous cell carcinoma
Date of disclosure of the study information 2013/04/01
Last modified on 2018/04/24 10:13:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase I/II study on completion rate of concurrent chemoradiotherapy which regimen is assumed by only CDDP for head and neck squamous cell carcinoma

Acronym

Concurrent chemoradiotherapy which regimen is assumed by only CDDP

Scientific Title

Phase I/II study on completion rate of concurrent chemoradiotherapy which regimen is assumed by only CDDP for head and neck squamous cell carcinoma

Scientific Title:Acronym

Concurrent chemoradiotherapy which regimen is assumed by only CDDP

Region

Japan


Condition

Condition

Head and neck cancer

Classification by specialty

Oto-rhino-laryngology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We decide maximum tolerated dose (MTD) and dose limiting toxicity (DLT) in concurrent chemoradiotherapy (CCRT) which regimen is assumed by only CDDP for head and neck cancer, and examine the effect and safety. The main end-point is MTD and DLT in phase I, and rate of CCRT completion in phase II.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Decision of MTD and DLT (phase I)
Rate of CCRT completion (phase II)

Key secondary outcomes

The adverse effect, rate of CCRT completion (Phase I)
Renal dysfunction more than grade 2, response rate, inflammation of mucosa more than grade 3, rate of chemotherapy completion (Phase II)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

3 courses of CDDP every 3 weeks during radiation therapy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1)Pathologic or cytologic diagnosis of head and neck squamous cell carcinoma treated with radical CCRT, ie, whole-neck irradiation including bilateral levels II-IV
2)Initial chemotherapy
3)Measurable or evaluable lesions
4)Performance status(PS) 0-1
5)Age 20-75 years
6)No complication that might affect treatment
7)No other cancer
8)Normal liver, kidney, and marrow function
White blood cells >3,000/ mm3
Neutrophilic >1,500/mm3
Blood platelet >100,000/mm3
Total bilirubin normal
AST and ALT normal
Creatinine normal
Ccr or eGFR >60ml/min
9)Written informed consent

Key exclusion criteria

1)Past history of serious drug hypersensitivity
2)Presence of other cancer
3)Clinically problematic infectious disease
4)>1 complication that might affect treatment
5) Nonradical treatment indicated
6)Pregnant or nursing women and those with the possibility of pregnancy
7)Mental or neurologic disease that might affect participation
8)Participation judged by physician to be inadvisable

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hiroshi Matsuyama

Organization

Niigata University, Faculty of Medicine

Division name

Otolaryngology, Head and Neck

Zip code


Address

1-757 Asahimachi-dori, Chuo-ku, Niigata-shi, Niigata-ken

TEL

+81-25-227-2306

Email

matsuhiroshi@med.niigata-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hiroshi Matsuyama

Organization

Niigata University, Faculty of Medicine

Division name

Otolaryngology, Head and Neck

Zip code


Address

1-757 Asahimachi-dori, Chuo-ku, Niigata-shi, Niigata-ken

TEL

+81-25-227-2306

Homepage URL


Email

matsuhiroshi@med.niigata-u.ac.jp


Sponsor or person

Institute

Niigata University, Faculty of Medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Niigata Cancer Center Hospital
Niigata City General Hospital
Nagaoka Red Cross Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

新潟大学医歯学総合病院(新潟県)
新潟県立がんセンター新潟病院(新潟県)
新潟市民病院(新潟県)
長岡赤十字病院(新潟県)


Other administrative information

Date of disclosure of the study information

2013 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

Phase II study was finished
Now stand-by for published of main results

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2013 Year 04 Month 01 Day

Date of IRB


Anticipated trial start date

2013 Year 11 Month 01 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry

2017 Year 08 Month 20 Day

Date trial data considered complete

2017 Year 08 Month 20 Day

Date analysis concluded

2017 Year 08 Month 20 Day


Other

Other related information



Management information

Registered date

2013 Year 03 Month 31 Day

Last modified on

2018 Year 04 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000012134


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name